IDEXX Laboratories Long Term Debt 2011-2025 | IDXX
IDEXX Laboratories long term debt from 2011 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- IDEXX Laboratories long term debt for the quarter ending June 30, 2025 was $0.450B, a 14.28% decline year-over-year.
- IDEXX Laboratories long term debt for 2024 was $0.45B, a 27.79% decline from 2023.
- IDEXX Laboratories long term debt for 2023 was $0.623B, a 10.3% decline from 2022.
- IDEXX Laboratories long term debt for 2022 was $0.694B, a 10.43% decline from 2021.
|
IDEXX Laboratories Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $450 |
| 2023 | $623 |
| 2022 | $694 |
| 2021 | $775 |
| 2020 | $858 |
| 2019 | $699 |
| 2018 | $601 |
| 2017 | $606 |
| 2016 | $593 |
| 2015 | $597 |
| 2014 | $350 |
| 2013 | $150 |
| 2012 | $1 |
| 2011 | $3 |
| 2010 | $3 |
|
IDEXX Laboratories Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-06-30 | $450 |
| 2025-03-31 | $450 |
| 2024-12-31 | $450 |
| 2024-09-30 | $525 |
| 2024-06-30 | $525 |
| 2024-03-31 | $621 |
| 2023-12-31 | $623 |
| 2023-09-30 | $619 |
| 2023-06-30 | $697 |
| 2023-03-31 | $696 |
| 2022-12-31 | $694 |
| 2022-09-30 | $761 |
| 2022-06-30 | $768 |
| 2022-03-31 | $773 |
| 2021-12-31 | $775 |
| 2021-09-30 | $778 |
| 2021-06-30 | $780 |
| 2021-03-31 | $779 |
| 2020-12-31 | $858 |
| 2020-09-30 | $853 |
| 2020-06-30 | $900 |
| 2020-03-31 | $697 |
| 2019-12-31 | $699 |
| 2019-09-30 | $697 |
| 2019-06-30 | $701 |
| 2019-03-31 | $699 |
| 2018-12-31 | $601 |
| 2018-09-30 | $665 |
| 2018-06-30 | $603 |
| 2018-03-31 | $609 |
| 2017-12-31 | $606 |
| 2017-09-30 | $604 |
| 2017-06-30 | $601 |
| 2017-03-31 | $595 |
| 2016-12-31 | $593 |
| 2016-09-30 | $630 |
| 2016-06-30 | $598 |
| 2016-03-31 | $600 |
| 2015-12-31 | $597 |
| 2015-09-30 | $600 |
| 2015-06-30 | $623 |
| 2015-03-31 | $522 |
| 2014-12-31 | $350 |
| 2014-09-30 | $372 |
| 2014-06-30 | $150 |
| 2014-03-31 | $150 |
| 2013-12-31 | $150 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $1 |
| 2012-09-30 | $2 |
| 2012-06-30 | $2 |
| 2012-03-31 | $2 |
| 2011-12-31 | $3 |
| 2011-09-30 | $3 |
| 2011-06-30 | $3 |
| 2011-03-31 | $3 |
| 2010-12-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $56.892B | $3.898B |
| IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.349B | 26.18 |
| Intuitive Surgical (ISRG) | United States | $205.110B | 80.25 |
| Edwards Lifesciences (EW) | United States | $49.418B | 33.14 |
| Alcon (ALC) | Switzerland | $38.157B | 25.79 |
| IQVIA Holdings (IQV) | United States | $37.216B | 20.75 |
| Mettler-Toledo (MTD) | United States | $29.520B | 34.54 |
| STERIS (STE) | Ireland | $26.176B | 27.02 |
| Waters (WAT) | United States | $22.989B | 30.41 |
| DexCom (DXCM) | United States | $22.672B | 31.25 |
| Hologic (HOLX) | United States | $16.592B | 17.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.147B | 0.00 |
| Globus Medical (GMED) | United States | $11.472B | 23.86 |
| Penumbra (PEN) | United States | $10.953B | 77.05 |
| Masimo (MASI) | United States | $7.879B | 25.25 |
| Sysmex ADR (SSMXY) | Japan | $6.616B | 21.02 |
| Glaukos (GKOS) | United States | $5.163B | 0.00 |
| Teleflex (TFX) | United States | $4.961B | 7.91 |
| TransMedics (TMDX) | United States | $4.174B | 49.45 |
| Veracyte (VCYT) | United States | $3.372B | 38.43 |
| Alphatec Holdings (ATEC) | United States | $3.078B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.877B | 15.54 |
| Integer Holdings (ITGR) | United States | $2.446B | 11.48 |
| Artivion (AORT) | United States | $2.220B | 101.87 |
| Nihon Kohden (NHNKY) | Japan | $1.815B | 15.84 |
| PROCEPT BioRobotics (PRCT) | United States | $1.751B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.710B | 16.57 |
| Beta Bionics (BBNX) | United States | $1.269B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.188B | 0.00 |
| AxoGen (AXGN) | United States | $1.128B | 0.00 |
| IRadimed (IRMD) | United States | $1.077B | 51.30 |
| Pulse Biosciences (PLSE) | United States | $1.038B | 0.00 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.960B | 5.20 |
| SiBone (SIBN) | United States | $0.791B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.607B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.562B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.561B | 32.60 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.541B | 10.80 |
| AngioDynamics (ANGO) | United States | $0.520B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.495B | 0.00 |
| NeuroPace (NPCE) | United States | $0.449B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.442B | 12.20 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| RxSight (RXST) | United States | $0.421B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.414B | 3.25 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.334B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.312B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.71 |
| CVRx (CVRX) | United States | $0.258B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.214B | 0.00 |
| 908 Devices (MASS) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.139B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.53 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |